Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA.
Bone marrow transplantation shows potential for treating adults with severe sickle cell disease
- For older adults with pneumonia, azithromycin lowers risk of death, slightly increases risk of heart attack
- Extended follow-up of hormone therapy trials does not support use for chronic disease prevention
- Greater density of coronary artery calcium associated with lower risk of coronary heart disease
- Wide variation found in evidence used by FDA for approval of new drugs
- Use of vitamin E by patients with mild to moderate Alzheimer disease slows functional decline